4WTH
Ataxin-3 Carboxy Terminal Region - Crystal C2 (triclinic)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 19-ID |
Synchrotron site | APS |
Beamline | 19-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-10-10 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.987 |
Spacegroup name | P 1 |
Unit cell lengths | 49.096, 59.786, 77.790 |
Unit cell angles | 90.00, 89.99, 87.50 |
Refinement procedure
Resolution | 77.790 - 2.250 |
R-factor | 0.20424 |
Rwork | 0.202 |
R-free | 0.24975 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1anf |
RMSD bond length | 0.007 |
RMSD bond angle | 1.117 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.6.0117) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 38.743 | 2.360 |
High resolution limit [Å] | 2.250 | 2.250 |
Rmerge | 0.047 | |
Number of reflections | 39115 | |
<I/σ(I)> | 15.7 | 1.2 |
Completeness [%] | 94.0 | 76 |
Redundancy | 1.9 | 1.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 277 | 24% PEG5000 MME, 0.9 M sodium acetate, 0.06 M imidazole, pH 8.0, 0.1 M zinc acetate |